维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="Channick R"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension显示文摘	Khanna D Gladue H Channick R	2013	Arthritis Rheum2013，65，12：	1
2	Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension:a randomized placebo-controlled study显示文摘	Channick R N Simonneau G Sitbon O	2001	Lancet2001，358，9287：	1
3	Maciten- tan and morbidity and mortality in pulmonary arterial hyper- tension显示文摘	PULIDO T ADZERIKHO I CHANNICK R N	2013	N Engl J Med2013，369，：	1
4	Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension:A randomized placebo controlled study显示文摘	Channick R Sunomeau G Sitbon O	2001	Lancet2001，358，23：	1
5	Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension:a randomised placebo-eontrolhd study显示文摘	Channick R N Simonneau G Sitbon O	2001	Lancet2001，358，9288：	1
6	Selexipag for the treatment of pulmonary arterial hypertension显示文摘	Sitbon O Channick R Chin KM	2015	N Engl J Med2015，373，26：	1
7	Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension:a 1-year follow-up study显示文摘	SITBON O BADESCH D B CHANNICK R N	2003	Chest2003，124，：	1
8	Selexipag for the treatment of pulmonary arterial hypertension显示文摘	SITBON O CHANNICK R CHIN KM	2015	N Engl J Med2015，373，26：	1
9	Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: a placebo-controlled study显示文摘	Channick R Badesch DB Tapson VF	2001	J Heart Lung Transplant2001，20，2：	1
10	Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension 显示文摘	HOEPER M M BARBERA J A CHANNICK R N	2009	J Am Coil Cardiol2009，54，3：	1
11	Macitentan and morbidity and mortality in pulmonary arterial hypertension 显示文摘	PULIDO T ADZERIKHO I CHANNICK R et ol	2013	New Engl J Med2013，369，9：	1
12	Addition of inhaled treprostinil to oraltherapy for pulmonary arterial hypertension:a randomized con-trolled clinical trial显示文摘	McLaughlin VV Benza RL Rubin LJ Channick RN Voswinck-el R Tapson VF	2010	J Am Coll Cardiol2010，55，18：	1
13	Efects of the dualendothelin-receptors antagonist bosentan in patients with pulmonary hypertension:a randomized placebo-controlled study显示文摘	Channick R N Simonneau G Sitbon O		0，，：	1
14	Chronic thromboembolic pulmonary hypertension显示文摘	Fedullo P F Auger W R Channick R N	2001	Clin Chest Med2001，22，3：	1
15	Endothelin receptor antagonists in pulmonary arterial hypertension 显示文摘	CHANNICK R N SITBON O BARST R J	2004	J Am Coll Cardiol2004，43，12：	1
16	Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterialhypertension:a 1-year follow up study显示文摘	SITBON O BADESCH D B CHANNICK R N	2003	Chest2003，124，1：	1
17	Effect of macitentan on morbidity and mortality in pulmonary arterial hypertension (PAIl): results from the SERAPHIN Trial显示文摘	Rubin L Pulido T Channick R	2012	Chest2012，142，4：	1
18	Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension:a randomized placebo-controlled study显示文摘	Channick R N Simonneau G Sitbon O Robbins I M Frost A Tapson V F	2001	Lancet2001，358，：	1
19	Selexipag for the treatment of pulmonary arterial hypertension显示文摘	SITBON O CHANNICK R CHIN KM	2015	N Engl J Med2015，373，26：	1
20	Endothelin receptor antagonism:a new era in the treatment of pulmonary arterial hypertension显示文摘	Channick R Rubin LJ	2002	Adv Pulm Hypn2002，1，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示